Sonnet Biotherapeutics Holdings Inc. buy Chardan Capital
Start price
16.08.23
/
50%
€0.38
Target price
16.08.24
€11.00
Performance (%)
-51.06%
End price
17.08.24
-
Summary
This prediction is currently being closed. The BUY prediction by Chardan_Capital for Sonnet Biotherapeutics Holdings Inc. is performing very badly with a performance of -51.06%. Chardan_Capital has a follow-up prediction for Sonnet Biotherapeutics Holdings Inc. where he still thinks Sonnet Biotherapeutics Holdings Inc. is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sonnet Biotherapeutics Holdings Inc. | - | - | - |
| iShares Core DAX® | 1.665% | 0.362% | 17.556% |
| iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% |
| iShares Nikkei 225® | 2.620% | 1.174% | 17.273% |
| iShares S&P 500 | -0.091% | -1.597% | 24.739% |
Comments by Chardan_Capital for this prediction
In the thread Sonnet Biotherapeutics Hldgs. Inc. diskutieren
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) had its price target lowered by analysts at Chardan Capital from $14.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for SONN provided by MarketBeat
In the thread Trading Sonnet Biotherapeutics Hldgs. Inc.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Sonnet Biotherapeutics Holdings Inc.
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
15.02.24
15.02.24
€27.86
15.02.25
15.02.25
-
20.11.23
20.11.23
Stopped prediction by Chardan_Capital for Sonnet Biotherapeutics Holdings Inc.
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
23.08.24
23.08.24
€26.85
23.08.25
23.08.25
-
20.11.23
20.11.23
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
28.05.24
28.05.24
€27.57
28.05.25
28.05.25
-
20.11.23
20.11.23